AZ1 Activators
AZ1 activators encompass a diverse set of chemical compounds that indirectly boost the functional activity of AZ1 through their influence on various cellular signaling pathways. Forskolin and IBMX, for instance, elevate the intracellular levels of cAMP which, in turn, activates PKA and deters the breakdown of cAMP and cGMP, respectively. This cascading effect on secondary messenger systems plays a pivotal role in enhancing the pathways in which AZ1 is directly involved, thereby leading to its functional activation. Similarly, PMA's activation of PKC and Ionomycin's calcium ionophore properties result in the phosphorylation of proteins within AZ1's signaling network, further potentiating AZ1's activity. LY294002 and U0126's inhibitory action on PI3K and MEK1/2, alongside SB203580's targeted p38 MAPK inhibition, redirects signaling towards the activation of AZ1. Rapamycin's suppression of mTOR and Sildenafil's PDE5 inhibition also contribute to the preferential activation of signaling pathways that align with AZ1's function.
The activation landscape of AZ1 is further shaped by chemicals that adjust intracellular calcium levels and kinase activities. A23187, by augmenting calcium concentrations, initiates a series of events that culminate in the activation of kinases impacting AZ1's activity. EGCG's ability to inhibit kinases that might restrain AZ1 activity ensures that the protein's activity is not only preserved but enhanced. Lastly, NAD+ serves as a precursor for coenzymes in redox reactions, which are integral to the functioning of sirtuins and poly(ADP-ribose) polymerases (PARPs). These enzymes participate in modifyingpost-translational modifications and altering signaling pathways that ultimately contribute to the upregulation of AZ1's activity. Through these multifaceted mechanisms, each AZ1 activator indirectly fosters a conducive environment for the enhancement of AZ1, thereby ensuring the amplification of its biological roles without the necessity of direct interaction or upregulation of its expression.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
By elevating cAMP levels, Forskolin activates Protein Kinase A (PKA). PKA then phosphorylates target proteins that can lead to the activation of AZ1 by promoting cellular processes that AZ1 is known to be involved in. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
As a non-selective inhibitor of phosphodiesterases, IBMX prevents the breakdown of cAMP and cGMP, thereby enhancing the signaling pathways that lead to the activation of AZ1. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is an activator of Protein Kinase C (PKC), which may phosphorylate proteins in pathways that AZ1 is involved in, thereby enhancing the functional activity of AZ1. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, which could activate calmodulin-dependent kinases and subsequently enhance AZ1 activity through downstream signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
As an inhibitor of PI3K, LY294002 shifts the balance of signaling towards pathways that AZ1 is directly involved in, enhancing the functional activity of AZ1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This compound inhibits p38 MAPK, which can lead to the preferential activation of pathways in which AZ1 is involved, thus enhancing the activity of AZ1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which can lead to the activation of alternate pathways that enhance the function of AZ1. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187, a calcium ionophore, increases intracellular calcium concentration, which could activate signaling pathways that indirectly lead to AZ1 enhancement. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a kinase inhibitor which may inhibit kinases that negatively regulate AZ1, thus leading to its enhanced activity. | ||||||
NAD+, Free Acid | 53-84-9 | sc-208084B sc-208084 sc-208084A sc-208084C sc-208084D sc-208084E sc-208084F | 1 g 5 g 10 g 25 g 100 g 1 kg 5 kg | $57.00 $191.00 $302.00 $450.00 $1800.00 $3570.00 $10710.00 | 4 | |
NAD+ acts as a substrate for sirtuins and PARPs that may have downstream effects on signaling pathways, enhancing the functional activity of AZ1. | ||||||